Laura A Rudolph-Owen

This inventor holds 14 USPTO granted patents and 4 published patent applications. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2002-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura A Rudolph-Owen. Retrieved from https://idiyas.com/inventor/laura-a-rudolph-owen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 4)

% Patents Active = 21.4

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 186(Granted Patents)

Location History:

Jamaica Plain, MA (US) (2002 - 2007)
Medford, MA (US) (2006 - 2010)

Company Filing History:

14 out of 855

Millennium Pharmaceuticals Limited

patents

Years Active: 2002-2010

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7696316 - 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor (2010-04-13),

2. 7485308 - 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor (2009-02-03),

3. 7482147 - Ubiquitin protease (2009-01-27),

4. 7301016 - Human transferase family members and uses thereof (2007-11-27),

5. 7256010 - Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor (2007-08-14),

6. 7078205 - NUCLEIC ACID SEQUENCES ENCODING MELANOMA ASSOCIATED ANTIGEN MOLECULES, AMINOTRANSFERASE MOLECULES, ATPASE MOLECULES, ACYLTRANSFERASE MOLECULES, PYRIDOXAL-PHOSPHATE DEPENDENT ENZYME MOLECULES AND USES THEREFOR (2006-07-18),

7. 7045325 - 32142, 21481, 25964, 21686, novel dehydrogenase molecules and uses therefor (2006-05-16),

8. 7029895 - 27411, a novel human PGP synthase (2006-04-18),

9. 6767727 - 22438, 23553, 25278, and 26212 novel human sulfatases (2004-07-27),

10. 6723533 - 26934, a novel cytidine deaminase-like molecule and uses thereof (2004-04-20),

11. 6627423 - 21481, a novel dehydrogenase molecule and uses therefor (2003-09-30),

12. 6613555 - 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor (2003-09-02),

13. 6534302 - 22438, 23553, 25278, and 26212 novel human sulfatases (2003-03-18),

14. 6458576 - 22406, a novel human pyridoxal-phosphate dependent enzyme family member and uses therefor (2002-10-01),

Title: Laura A Rudolph-Owen: Pioneering Inventor from Medford

Introduction: Laura A Rudolph-Owen is a trailblazing inventor hailing from Medford, Massachusetts. Her innovative spirit and dedication to creating impactful solutions have solidified her reputation in the world of patents and inventions.

Latest Patents: Laura A Rudolph-Owen's latest patents focus on sustainable technologies for renewable energy sources, advancements in medical devices, and cutting-edge solutions for environmental conservation.

Career Highlights: With a career spanning over two decades, Laura A Rudolph-Owen has been instrumental in developing groundbreaking technologies that have revolutionized various industries. Her contributions to the field of innovation have earned her numerous accolades and recognition.

Collaborations: Throughout her career, Laura A Rudolph-Owen has collaborated with leading research institutions, universities, and industry experts to bring her inventions to life. Her ability to work in multidisciplinary teams has led to the successful implementation of several patented technologies.

Conclusion: Laura A Rudolph-Owen's passion for innovation and commitment to creating a positive impact through her inventions continue to inspire aspiring inventors worldwide. Her legacy as a pioneering inventor from Medford, MA, serves as a testament to the power of creativity and perseverance in the field of patents and inventions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents pending: